Literature DB >> 27028556

Refractory Subcutaneous Sweet Syndrome Treated With Adalimumab.

Ashwin Agarwal1, Willis Barrow2, M Angelica Selim2, Matilda W Nicholas3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27028556     DOI： 10.1001/jamadermatol.2016.0503

Source DB:  PubMed          Journal:  JAMA Dermatol        ISSN： 2168-6068            Impact factor:   10.282


× No keyword cloud information.
  5 in total

Review 1.  Cutaneous Manifestations of Inflammatory Bowel Disease: A Basic Overview.

Authors:  Kyla Pagani; Danitza Lukac; Aashni Bhukhan; Jean S McGee
Journal:  Am J Clin Dermatol       Date:  2022-04-20       Impact factor: 6.233

2.  Systematic Review: Sweet Syndrome Associated with Inflammatory Bowel Disease.

Authors:  Joseph Sleiman; Asif A Hitawala; Benjamin Cohen; Katie Falloon; Marian Simonson; Benjamin Click; Urmi Khanna; Anthony P Fernandez; Florian Rieder
Journal:  J Crohns Colitis       Date:  2021-11-08       Impact factor: 9.071

3.  A Sweet Diagnosis for a Non-Resolving Rash.

Authors:  Jian Liang Tan; Kah Poh Loh; Kshitij Thakur; Edward F Chan; Arezoo Ghaneie
Journal:  Cureus       Date:  2018-04-22

Review 4.  Insights Into the Pathogenesis of Sweet's Syndrome.

Authors:  Michael S Heath; Alex G Ortega-Loayza
Journal:  Front Immunol       Date:  2019-03-12       Impact factor: 7.561

Review 5.  Learning From Success and Failure: Biologics for Non-approved Skin Diseases.

Authors:  Reinhart Speeckaert; Jo Lambert; Nanja van Geel
Journal:  Front Immunol       Date:  2019-08-08       Impact factor: 7.561
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.